Brief: Australian Clinical Labs Served With Representative Proceeding
21/04/2026 02:14
April 21 (Reuters) - Australian Clinical Labs Ltd ACL.AX: SERVED WITH A REPRESENTATIVE PROCEEDING FILED IN SUPREME COURT OF VICTORIA ACL DENIES BREACHES ALLEGED IN CLAIM AND INTENDS TO VIGOROUSLY DEFEND IT STATEMENT OF CLAIM PURPORTS TO SEEK DAMAGES FOR ALLEGEDLY AFFECTED INDIVIDUALS STATEMENT OF CLAIM ON ALLEGED BREACHES OF S60 OF AUSTRALIAN CONSUMER LAW, OTHERS Further company coverage: ACL.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Australian Clinical Labs
See all newsBrief: Australian Clinical Labs Appoints Deloitte As Auditor
Australia's Optiscan rises after imaging more than 80 cases in ACL study
Australian Clinical Labs falls to over two-week low on trading ex-dividend
Australian Clinical Labs at 6-month high on upbeat full-year results, guidance
Brief: Australian Clinical Labs Says It Expects FY27 Revenue Of A$745-765 Million